Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | EBP | Q15125 | 1/20 | 0.47 |
| ▸ | DHCR7 | Q9UBM7 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3235228 | 1.00 | CYP2D6 (0.59) | CYP2D6CYP1A2PKMALDH1A1KDM4E | |
| SCHEMBL6863028 | 1.00 | CYP2D6 (0.59) | CYP2D6CYP1A2PKMALDH1A1KDM4E | |
| SCHEMBL8425188 | 0.92 | ALDH1A1 (0.56) | CYP2D6CYP1A2PKMALDH1A1KDM4E | |
| SCHEMBL6881853 | 0.92 | ALDH1A1 (0.56) | CYP2D6CYP1A2PKMALDH1A1KDM4E | |
| SCHEMBL8879797 | 0.91 | CYP2D6 (0.66) | CYP2D6CYP1A2PKMALDH1A1KDM4E | |
| SCHEMBL841102 | 0.89 | DHCR7 (0.53) | CYP2D6CYP1A2KMT2AMEN1MAPT | |
| SCHEMBL20594955 | 0.89 | CYP2D6 (0.59) | CYP2D6CYP1A2PKMALDH1A1KDM4E | |
| SCHEMBL7466566 | 0.86 | ALDH1A1 (0.49) | CYP2D6CYP1A2PKMALDH1A1KDM4E | |
| SCHEMBL24479773 | 0.85 | HSD11B1 (0.54) | PKMALDH1A1KDM4EPOLBHTT | |
| SCHEMBL420300 | 0.82 | CYP2D6 (0.74) | CYP2D6CYP1A2PKMPOLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2109601-A2 | PREPARATION OF DARIFENACIN AND ITS SALTS | Dr. Reddy's Laboratories Ltd. (IN) | 2009-10-21 | — | — | EP | claimed |
| WO-2009125430-A2 | IMPROVED PROCESS FOR PRODUCING DARIFENACIN | MATRIX LABORATOIRES LIMITED (IN) | 2009-10-15 | — | — | WO | claimed |
| WO-2008100651-A2 | PREPARATION OF DARIFENACIN AND ITS SALTS | DR. REDDY'S LABORATORIES LTD. (IN) | 2008-08-21 | — | — | WO | claimed |
| WO-2009125430-A3 | IMPROVED PROCESS FOR PRODUCING DARIFENACIN | MATRIX LABORATOIRES LIMITED (IN) | 2010-04-22 | — | — | WO | disclosed |
| WO-2009125430-A8 | IMPROVED PROCESS FOR PRODUCING DARIFENACIN | MATRIX LABORATOIRES LIMITED (IN) | 2010-01-21 | — | — | WO | disclosed |
| WO-2009153649-A1 | PROCESS FOR PREPARING 3-SUBSTITUTED PYRROLIDINE COMPOUNDS | MEDICHEM, S.A. (ES) | 2009-12-23 | — | — | WO | disclosed |
| EP-2109601-A2 | PREPARATION OF DARIFENACIN AND ITS SALTS | Dr. Reddy's Laboratories Ltd. (IN) | 2009-10-21 | — | — | EP | disclosed |
| WO-2009125430-A2 | IMPROVED PROCESS FOR PRODUCING DARIFENACIN | MATRIX LABORATOIRES LIMITED (IN) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009125430-A2 | IMPROVED PROCESS FOR PRODUCING DARIFENACIN | MATRIX LABORATOIRES LIMITED (IN) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009125430-A2 | IMPROVED PROCESS FOR PRODUCING DARIFENACIN | MATRIX LABORATOIRES LIMITED (IN) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009125426-A2 | NOVEL PROCESS FOR THE PREPARATION OF (3SM-[2-(2 J-DIHYDRO-5- BENZOFURANYLϊETHYL]-α.α -DIPHENYL-3-PYRROLIDINEACETAMIDE HYDROBROMIDE | NEULAND LABORATORIES LTD (IN) | 2009-10-15 | — | — | WO | disclosed |
| US-5281601-A | Imide substituted indoline derivatives | PFIZER INC. (US) | 1994-01-25 | — | — | US | disclosed |
| EP-0388054-B1 | Pyrrolidine derivatives | PFIZER LTD (GB) | 1993-11-03 | — | — | EP | disclosed |
| US-5233053-A | Pyrrolidine derivatives | PFIZER INC. (US) | 1993-08-03 | — | — | US | disclosed |
| EP-0505376-A1 | MUSCARINIC RECEPTOR ANTAGONISTS. | PFIZER LTD (GB) | 1992-09-30 | — | — | EP | disclosed |
| EP-0505377-A1 | MUSCARINIC RECEPTOR ANTAGONISTS. | PFIZER LTD (GB) | 1992-09-30 | — | — | EP | disclosed |
| US-5096890-A | PYRROLIDINE DERIVATIVES | PFIZER INC. (US) | 1992-03-17 | — | — | US | disclosed |
| WO-1991009015-A1 | MUSCARINIC RECEPTOR ANTAGONISTS | PFIZER LIMITED (GB) | 1991-06-27 | — | — | WO | disclosed |
| WO-1991009013-A1 | MUSCARINIC RECEPTOR ANTAGONISTS | PFIZER LIMITED (GB) | 1991-06-27 | — | — | WO | disclosed |
| EP-0388054-A1 | Pyrrolidine derivatives | Pfizer Limited (GB) | 1990-09-19 | — | — | EP | disclosed |